WuXi AppTec Co. Ltd
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $35.67 billion
- Book Value:
- Revenue TTM:
- $39.35 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $14.68 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
WuXi AppTec Co. Ltd had its IPO on under the ticker symbol WUXAY.
The company operates in the Healthcare sector and Diagnostics & Research industry. WuXi AppTec Co. Ltd has a staff strength of 0 employees.
Shares of WuXi AppTec Co. Ltd opened at $10.52 at the start of the last trading session i.e. 2023-03-23.
The stocks traded within a range of $10.49 - $10.66, and closed at $10.66.
This is a +5.01% increase from the previous day's closing price.
A total volume of 1,359 shares were traded at the close of the day’s session.
In the last one week, shares of WuXi AppTec Co. Ltd have increased by +6.61%.
WuXi AppTec Co. Ltd's Key Ratios
WuXi AppTec Co. Ltd has a market cap of $35.67 billion, indicating a price to book ratio of 4.6305 and a price to sales ratio of 0.9452.
In the last 12-months WuXi AppTec Co. Ltd’s revenue was $39.35 billion with a gross profit of $14.68 billion and an EBITDA of $11.24 billion. The EBITDA ratio measures WuXi AppTec Co. Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, WuXi AppTec Co. Ltd’s operating margin was 24.77% while its return on assets stood at 10.17% with a return of equity of 20.78%.
In Q3, WuXi AppTec Co. Ltd’s quarterly earnings growth was a negative -5.7% while revenue growth was a positive 71.8%.
WuXi AppTec Co. Ltd’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.44 per share while it has a forward price to earnings multiple of 19.802 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into WuXi AppTec Co. Ltd’s profitability.
WuXi AppTec Co. Ltd stock is trading at a EV to sales ratio of 0.9451 and a EV to EBITDA ratio of 3.072. Its price to sales ratio in the trailing 12-months stood at 0.9452.
WuXi AppTec Co. Ltd stock pays annual dividends of $0 per share, indicating a yield of 0.84% and a payout ratio of 21.89%.
Balance sheet and cash flow metrics
- Total Assets
- $65.75 billion
- Total Liabilities
- $17.47 billion
- Operating Cash Flow
- Capital Expenditure
- $2.33 billion
- Dividend Payout Ratio
WuXi AppTec Co. Ltd ended 2023 with $65.75 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $65.75 billion while shareholder equity stood at $44.81 billion.
WuXi AppTec Co. Ltd ended 2023 with $1.69 billion in deferred long-term liabilities, $17.47 billion in other current liabilities, 2960419498.00 in common stock, $18.40 billion in retained earnings and $1.93 billion in goodwill. Its cash balance stood at $9.21 billion and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $880.28 million.
WuXi AppTec Co. Ltd’s total current assets stands at $25.46 billion while long-term investments were $0 and short-term investments were $70.20 million. Its net receivables were $7.32 billion compared to accounts payable of $1.84 billion and inventory worth $6.58 billion.
In 2023, WuXi AppTec Co. Ltd's operating cash flow was $-2120854885.00 while its capital expenditure stood at $2.33 billion.
Comparatively, WuXi AppTec Co. Ltd paid $0.22 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
WuXi AppTec Co. Ltd stock is currently trading at $10.66 per share. It touched a 52-week high of $17.7639 and a 52-week low of $17.7639. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $11.67 and 200-day moving average was $10.94 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About WuXi AppTec Co. Ltd
Similar Industry Stocks (Diagnostics & Research)
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People’s Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.